Yigal Nochomovitz
Stock Analyst at Citigroup
(3.46)
# 957
Out of 5,124 analysts
330
Total ratings
44.87%
Success rate
5.73%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals | Maintains: Buy | $21 → $60 | $25.00 | +140.00% | 3 | Dec 12, 2025 | |
| DRTS Alpha Tau Medical | Maintains: Buy | $8 → $7 | $4.95 | +41.41% | 1 | Dec 10, 2025 | |
| LGND Ligand Pharmaceuticals | Initiates: Buy | $270 | $188.97 | +42.88% | 1 | Dec 9, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $12 → $16 | $8.18 | +95.60% | 7 | Nov 17, 2025 | |
| CADL Candel Therapeutics | Maintains: Buy | $25 → $24 | $5.65 | +324.78% | 2 | Nov 14, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Neutral | $12 → $9 | $6.13 | +46.82% | 8 | Nov 13, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $87 → $77 | $52.44 | +46.83% | 22 | Nov 12, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $33 → $31 | $20.12 | +54.08% | 4 | Nov 11, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $7 → $6 | $1.24 | +383.87% | 11 | Nov 10, 2025 | |
| ONC BeOne Medicines AG | Maintains: Buy | $399 → $405 | $303.81 | +33.31% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $5.64 | +148.23% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $166 → $198 | $246.54 | -19.69% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $5.83 | +88.68% | 16 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $1.59 | +403.14% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $45 | $25.12 | +79.14% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $56 | $23.83 | +135.00% | 9 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $203 | $141.83 | +43.13% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $46 | $36.31 | +26.69% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $26.71 | +23.55% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $17.49 | +128.70% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $97 | $90.00 | +7.78% | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $17.64 | +291.16% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $26.33 | -16.45% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.2 → $1.9 | $1.15 | +65.22% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $51 | $21.01 | +142.74% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $16.00 | +225.00% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $21.52 | -67.47% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.24 | +301.79% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $11.86 | -19.90% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $42.83 | +28.41% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $18.27 | +80.62% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.10 | +7,900.00% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $3.65 | -45.21% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $34.57 | +67.78% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.61 | +769.57% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.63 | -26.38% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.02 | -0.99% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.18 | +54.44% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $5.84 | -82.88% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $18.09 | +93.48% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $23.00 | +478.26% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $4.82 | +231.95% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.98 | +917.71% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.78 | +574.16% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.95 | - | 14 | Sep 28, 2021 |
Olema Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $21 → $60
Current: $25.00
Upside: +140.00%
Alpha Tau Medical
Dec 10, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.95
Upside: +41.41%
Ligand Pharmaceuticals
Dec 9, 2025
Initiates: Buy
Price Target: $270
Current: $188.97
Upside: +42.88%
ORIC Pharmaceuticals
Nov 17, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $8.18
Upside: +95.60%
Candel Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $5.65
Upside: +324.78%
Arcturus Therapeutics Holdings
Nov 13, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.13
Upside: +46.82%
CRISPR Therapeutics AG
Nov 12, 2025
Maintains: Buy
Price Target: $87 → $77
Current: $52.44
Upside: +46.83%
ArriVent BioPharma
Nov 11, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $20.12
Upside: +54.08%
Biomea Fusion
Nov 10, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $1.24
Upside: +383.87%
BeOne Medicines AG
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $303.81
Upside: +33.31%
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $5.64
Upside: +148.23%
Nov 4, 2025
Maintains: Neutral
Price Target: $166 → $198
Current: $246.54
Upside: -19.69%
Nov 3, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $5.83
Upside: +88.68%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $1.59
Upside: +403.14%
Oct 31, 2025
Maintains: Buy
Price Target: $52 → $45
Current: $25.12
Upside: +79.14%
Oct 29, 2025
Maintains: Buy
Price Target: $54 → $56
Current: $23.83
Upside: +135.00%
Oct 29, 2025
Maintains: Buy
Price Target: $175 → $203
Current: $141.83
Upside: +43.13%
Oct 28, 2025
Maintains: Buy
Price Target: $27 → $46
Current: $36.31
Upside: +26.69%
Oct 21, 2025
Initiates: Buy
Price Target: $33
Current: $26.71
Upside: +23.55%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $17.49
Upside: +128.70%
Sep 29, 2025
Downgrades: Neutral
Price Target: $101 → $97
Current: $90.00
Upside: +7.78%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $17.64
Upside: +291.16%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $26.33
Upside: -16.45%
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.15
Upside: +65.22%
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $21.01
Upside: +142.74%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $16.00
Upside: +225.00%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $21.52
Upside: -67.47%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.24
Upside: +301.79%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $11.86
Upside: -19.90%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $42.83
Upside: +28.41%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $18.27
Upside: +80.62%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.10
Upside: +7,900.00%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $3.65
Upside: -45.21%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $34.57
Upside: +67.78%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.61
Upside: +769.57%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.63
Upside: -26.38%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.02
Upside: -0.99%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.18
Upside: +54.44%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $5.84
Upside: -82.88%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $18.09
Upside: +93.48%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $23.00
Upside: +478.26%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $4.82
Upside: +231.95%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $0.98
Upside: +917.71%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.78
Upside: +574.16%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.95
Upside: -